Harmony Biosciences Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Stockholders held by Harmony Biosciences Holdings, Inc. on May 15, 2025. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol HRMY.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes and Voting Results
A total of 45,446,787 shares were represented at the meeting, constituting a quorum. Stockholders voted on two proposals:
- Proposal 1 (Director Elections): Three Class II directors were elected to serve until the 2028 Annual Meeting.
- Juan A. Sabater: 25,912,106 votes For; 18,003,743 votes Withheld.
- Gary Sender: 35,048,612 votes For; 8,867,237 votes Withheld.
- Linda Szyper: 34,911,566 votes For; 9,004,283 votes Withheld.
- Proposal 2 (Auditor Ratification): The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
- Votes For: 44,691,094
- Votes Against: 738,550
- Abstain: 17,143
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the significant number of votes withheld for director Juan A. Sabater (18,003,743) compared to the other nominees.
- Confirm the total share count represented at the meeting (45,446,787) against the Company's total outstanding shares to assess participation rates.
- Review the definitive proxy statement filed on April 4, 2025, for detailed biographies of the elected directors and the rationale for the auditor appointment.